The positive and the negative impacts of spasticity in patients with long-term neurological conditions: an observational study

References

• Martin A, Abogunrin S, Kurth H, Dinet J. Epidemiological, humanistic, and economic burden of illness of lower limb spasticity in adults: a systematic review. Neuropsychiatr Dis Treat. 2014;10:111–122.
   PubMed Web of Science ®Google Scholar
• Shilt JS, Seibert PS, Kadyan V. Optimal management for people with severe spasticity. Degener Neurol Neuromuscul Dis. 2012;2:133–140.
   PubMedGoogle Scholar
• Yelnik AP, Simon O, Parratte B, et al. How to clinically assess and treat muscle overactivity in spastic paresis. J Rehabil Med. 2010;42(9):801–807.
   PubMed Web of Science ®Google Scholar
• Royal College of Physicians [Internet]. London: RCP; c1518–2019. Spasticity in adults: management using botulinum toxin; 2018 [cited 2019 Jun 5]. Available from: https://www.rcplondon.ac.uk/guidelinespolicy/spasticityadultsmanagement-using-botulinum-toxin
   Google Scholar
• World Health Organization [Internet]. Geneva: WHO; c1948–2019. International Classification of Functioning, Disability and Health (ICF); 2001 [cited 2018 Jun 5]. Available from: https://www.who.int/classifications/icf/en/
   Google Scholar
• Cook K, Williams A, Teal C, et al. The Patient-Reported Impact of Spasticity Measure (PRISM): a new measure assessing the impact of spasticity on persons with spinal cord injury. J Neurol Phys Ther. 2005;29(4):204–205.
   Google Scholar
• Cook KF, Teal CR, Engebretson JC, et al. Development and validation of Patient Reported Impact of Spasticity Measure (PRISM). JRRD. 2007;44(3):363–371.
   PubMedGoogle Scholar
• Adams MM, Ginis KAM, Hicks AL. The spinal cord injury spasticity evaluation tool: development and evaluation. Arch Phys Med Rehabil. 2007;88(9):1185–1192.
   PubMed Web of Science ®Google Scholar
• Ertzgaard P, Nene A, Kiekens C, et al. A review and evaluation of patient reported outcome measures for spasticity in persons with spinal cord damage: recommendations from the Ability Network – an international initiative. J Spinal Cord Med. 2019. DOI:https://doi.org/10.1080/10790268.2019.1575533
   Google Scholar
• Nogueira LAC, Nóbrega FR, Lopes KN, et al. The effect of functional limitations and fatigue on the quality of life in people with multiple sclerosis. Arq Neuro-Psiquiatr. 2009;63(3B):812–817.
   Google Scholar
• Voerman GE, Erren-Wolters CV, Fleuren JF, et al. Perceived spasticity in chronic spinal cord injured patients: associations with psychological factors. Disabil Rehabil. 2010;32(9):775–780.
   PubMed Web of Science ®Google Scholar
• Gillard PJ, Sucharew H, Kleindorfer D, et al. The negative impact of spasticity on the health-related quality of life of stroke survivors: a longitudinal cohort study. Health Qual Life Outcomes. 2015;13(1):159.
   PubMedGoogle Scholar
• Hotter B, Padberg I, Liebenau A, et al. Identifying unmet needs in long-term stroke care using in-depth assessment and the Post-Stroke Checklist – The Managing Aftercare for Stroke (MAS-I) study. Eur Stroke J. 2018;3(3):237–245.
   PubMed Web of Science ®Google Scholar
• Flachenecker P, Henze T, Zettl UK. Spasticity in patients with multiple sclerosis – clinical characteristics, treatment and quality of life. Acta Neurol Scand. 2014;129(3):154–162.
   PubMed Web of Science ®Google Scholar
• Knezevic T, Konstantinovic L, Rodic S, et al. Validity and reliability of the Serbian version of Patient-Reported Impact of Spasticity Measure in multiple sclerosis. Int J Rehabil Res. 2015;38(3):199–205.
   PubMed Web of Science ®Google Scholar
• Cheung J, Rancourt A, Di Poce S, et al. Patient-identified factors that influence spasticity in people with stroke and multiple sclerosis receiving botulinum toxin injection treatments. Physiother Can. 2015;67(2):157–166.
   PubMed Web of Science ®Google Scholar
• Platz T, Vuadens P, Eickhof C, et al. REPAS, a summary rating scale for resistance to passive movement: item selection, reliability and validity. Disabil Rehabil. 2008;30(1):44–53.
   PubMed Web of Science ®Google Scholar
• Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner. 1964;192:540–542.
   PubMedGoogle Scholar
• Bohannon R, Smith MB. Interrater reliability of a modified Ashworth sclae of muscle spasticity. Phys Ther. 1987;67(2):206–207.
   PubMed Web of Science ®Google Scholar
• Ward AB, Wissel J, Borg J, et al. Functional goal achievement in post-stroke spasticity patients: the Botox® Economic Spasticity Trial (BEST). J Rehabil Med. 2014;46(6):504–513.
   PubMed Web of Science ®Google Scholar
• Hair JF, Anderson RE, Tatham RL, et al. Multivariate data analysis (Vol. 6). Upper Saddle River (NJ): Prentice Hall; 1998.
   Google Scholar
• McKay WB, Sweatman WM, Field-Fote EC. The experience of spasticity after spinal cord injury: perceived characteristics and impact on daily life. Spinal Cord. 2018;56(5):478–486.
   PubMed Web of Science ®Google Scholar
• Brenes GA, Penninx B, Judd PH, et al. Anxiety, depression and disability across the lifespan. Aging Ment Health. 2008;12(1):158–163.
   PubMed Web of Science ®Google Scholar
• Kargarfard M, Eetemadifar M, Mehrabi M, et al. Fatigue, depression, and health related quality of life in patients with multiple sclerosis in Isfahan, Iran. Eur J Neurol. 2012;19(3):431–437.
   PubMed Web of Science ®Google Scholar
• Sheean G. Botulinum toxin treatment of adult spasticity. Drug Saf. 2006;29(1):31–48.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence [Internet]. London and Manchester: NICE; c.1999–2019. Cerebral palsy in under 25s: assessment and management NICE guideline [NG62]; 2017 [2019 Jun 8]. Available from: https://www.nice.org.uk/guidance/ng62.
   Google Scholar
• Synnot A, Chau M, Pitt V, et al. Interventions for managing skeletal muscle spasticity following traumatic brain injury. Cochrane Database Syst Rev. 2017;(11):CD008929.
   PubMedGoogle Scholar
• Milinis K, Young CA. Systematic review of the influence of spasticity on quality of life in adults with chronic neurological conditions. Disabil Rehabil. 2016;38(15):1431–1441.
   PubMed Web of Science ®Google Scholar
• Andresen SR, Biering-Sørensen F, Hagen EM, et al. Pain, spasticity and quality of life in individuals with traumatic spinal cord injury in Denmark. Spinal Cord. 2016;54(11):973–979.
   PubMed Web of Science ®Google Scholar
• Doan QV, Brashear A, Gillard PJ, et al. Relationship between disability and health-related quality of life and caregiver burden in patients with upper limb poststroke spasticity. PM&R. 2012;4(1):4–10.
   Web of Science ®Google Scholar
• Milinis K, Tennant A, Young CA. Spasticity in multiple sclerosis: associations with impairments and overall quality of life. Mult Scler Relat Disord. 2016;5:34–39.
   PubMed Web of Science ®Google Scholar
• Mutlu A, Livanelioglu A, Gunel MK. Reliability of Ashworth and Modified Ashworth Scales in children with spastic cerebral palsy. BMC Musculoskelet Disord. 2008;9(1):1–8.
   PubMedGoogle Scholar
• Meseguer-Henarejos AB, Sánchez-Meca J, López-Pina JA, et al. Inter- and intrarater reliability of the Modfied Ashworth scale: a systematic review and metaanalysis. Eur J Phys Rehabil Med. 2018;54(4):576–590.
   PubMed Web of Science ®Google Scholar